Exploring how nitric oxide affects the anticancer activity of etoposide and adriamycin in melanoma cells
Explore how DFG-out binding mode BRAF inhibitors are transforming melanoma treatment by targeting both monomeric and dimeric BRAF mutations.
Explore the groundbreaking development of personalized cancer vaccines using virus-like particles to target melanoma-specific T-cell epitopes